Derek J. Maetzold
Pres. & Chief Exec. Officer at Castle Biosciences. Based in Friendswood, Texas.
- Rank
- 11347th of 14,644
- Companies held
- 1
- Largest holding
- CSTL, 100.0% of total
- Latest SEC filing
- Nov 16, 2026
What the $7.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Castle Biosciences CSTL Common Stock | Through DJM Grantor Retained Annuity Trust No. 5 | 85,959 | $33.41 | $2.9M | 40.8% | Form 4, Jun 1, 2026 |
| Castle Biosciences CSTL Common Stock | Through DJM Grantor Retained Annuity Trust No. 8 | 40,935 | $33.41 | $1.4M | 19.4% | Form 4, Nov 16, 2026 |
| Castle Biosciences CSTL Common Stock | Through DJM Grantor Retained Annuity Trust No. 7 | 27,862 | $33.41 | $931K | 13.2% | Form 4, Nov 16, 2026 |
| Castle Biosciences CSTL Common Stock | DJM Grantor Retained Annuity Trust No. 9 | 23,216 | $33.41 | $776K | 11.0% | Form 4, Nov 16, 2026 |
| Castle Biosciences CSTL Common Stock | Through DJM Grantor Retained Annuity Trust No. 6 | 11,963 | $33.41 | $400K | 5.7% | Form 4, Nov 16, 2026 |
| Castle Biosciences CSTL Common Stock | Through The Maetzold 2018 Remainder Trust FBO John Derek Maetzold | 11,256 | $33.41 | $376K | 5.3% | Form 4, Nov 16, 2026 |
| Castle Biosciences CSTL Common Stock | Indirectly (see filing footnote) | 9,550 | $33.41 | $319K | 4.5% | Form 4, Sep 21, 2026 |
Share counts are the amounts Derek J. Maetzold reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sold | CSTL | 3,904 | $32.92 | $129K | View |
| Nov 16, 2026 | Sold | CSTL | 1,642 | $32.92 | $54K | View |
| Nov 16, 2026 | Sold | CSTL | 1,396 | $32.92 | $46K | View |
| Nov 2, 2026 | Sold | CSTL | 7,555 | $36.01 | $272K | View |
| Nov 2, 2026 | Sold | CSTL | 2,816 | $36.01 | $101K | View |
| Nov 2, 2026 | Sold | CSTL | 2,393 | $36.01 | $86K | View |
| Nov 2, 2026 | Sold | CSTL | 1,025 | $36.81 | $38K | View |
| Nov 2, 2026 | Sold | CSTL | 382 | $36.81 | $14K | View |
| Nov 2, 2026 | Sold | CSTL | 325 | $36.81 | $12K | View |
| Oct 19, 2026 | Sold | CSTL | 8,580 | $31.91 | $274K | View |
| Oct 19, 2026 | Sold | CSTL | 3,198 | $31.91 | $102K | View |
| Oct 19, 2026 | Sold | CSTL | 2,718 | $31.91 | $87K | View |
| Oct 5, 2026 | Sold | CSTL | 8,580 | $35.57 | $305K | View |
| Oct 5, 2026 | Sold | CSTL | 3,198 | $35.57 | $114K | View |
| Oct 5, 2026 | Sold | CSTL | 2,718 | $35.57 | $97K | View |
| Sep 21, 2026 | Sold | CSTL | 2,718 | $35.33 | $96K | View |
| Sep 21, 2026 | Sold | CSTL | 3,198 | $35.33 | $113K | View |
| Sep 21, 2026 | Sold | CSTL | 8,580 | $35.33 | $303K | View |
| Sep 11, 2026 | Sold | CSTL | 8,361 | $32.00 | $268K | View |
| Sep 11, 2026 | Sold | CSTL | 3,124 | $32.00 | $100K | View |
| Sep 11, 2026 | Sold | CSTL | 2,656 | $32.00 | $85K | View |
| Sep 11, 2026 | Sold | CSTL | 71 | $32.78 | $2K | View |
| Sep 11, 2026 | Sold | CSTL | 83 | $32.78 | $3K | View |
| Sep 11, 2026 | Sold | CSTL | 223 | $32.78 | $7K | View |
| Aug 28, 2026 | Sold | CSTL | 2,505 | $33.14 | $83K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 11344 | R. Scot Sellers Director, Howard Hughes Holdings. The Woodlands, TX | $7.0M |
| 11345 | Orion Hindawi Director, Pershing Square. New York, NY | $7.0M |
| 11346 | Jennifer Somers Chief Operations Officer, CAVA Group. Washington, DC | $7.0M |
| 11347 | Derek J. Maetzold Pres. & Chief Exec. Officer, Castle Biosciences. Friendswood, TX | $7.0M |
| 11348 | Nanci Caldwell Director, Procore Technologies. Carpinteria, CA | $7.0M |
| 11349 | Ann M. Kluppel SVP & Controller, Phillips 66. Houston, TX | $7.0M |
| 11350 | Gordon L. Johnson Director, Raymond James Financial. St. Petersburg, FL | $7.0M |
Questions
How much stock does Derek J. Maetzold own?
Derek J. Maetzold holds $7,039,803 in listed stock based on SEC filings and current prices, mostly Castle Biosciences (CSTL). That ranks 11347th on the Stock Rich List.
Is this Derek J. Maetzold's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Derek J. Maetzold last buy or sell stock?
The most recent open-market trade on file is a sale of 3,904 CSTL shares on Nov 16, 2026 at $32.92.